{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:45:08Z","timestamp":1773294308717,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/jcp.0b013e31825ac2cb","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T19:39:58Z","timestamp":1340221198000},"page":"548-550","source":"Crossref","is-referenced-by-count":37,"title":["Aripiprazole for the Treatment of Tourette Syndrome"],"prefix":"10.1097","volume":"32","author":[{"given":"Claudia","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Kleimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten R.","family":"M\u00fcller-Vahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","article-title":"Tourettes syndrome.","volume":"360","author":"Leckman","year":"2002","journal-title":"Lancet"},{"key":"R2-16-20210128","first-page":"578","article-title":"Un cas de maladie des tics de Gilles de la Tourette gueri par le R-1163.","volume":"119","author":"Seignot","year":"1961","journal-title":"Ann Med Psychol"},{"key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archpsyc.1973.01750310070010","article-title":"Treatment of Gilles de la Tourettes syndrome with haloperidol: review of 34 cases.","volume":"28","author":"Shapiro","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":". European clinical guidelines for Tourette syndrome and other tic disorders, part II: pharmacological treatment.","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.1C297","article-title":"Aripiprazole: a new atypical antipsychotic drug.","volume":"37","author":"Bowles","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":". The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R8-16-20210128","first-page":"S160","article-title":". Das temporale und extrastriatale D2D3-Rezeptor-Bindungsprofil von Aripiprazol bei Patienten mit schizophrener oder schizoaffektiver Psychose.","volume":"77","author":"Janouschek","year":"2006","journal-title":"Der Nervenarzt"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":". Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S1516-44462004000300015","article-title":". Aripiprazole and Tourette syndrome.","volume":"26","author":"Hounie","year":"2004","journal-title":"Rev Bras Psiquiatr"},{"key":"R11-16-20210128","first-page":"625","article-title":"Aripiprazole in a patient vulnerable to side effects.","volume":"162","author":"Dehning","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.jcp.0000150229.69124.66","article-title":". Treatment of tics in Tourette syndrome with aripiprazole.","volume":"25","author":"Kastrup","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S1461145705005365","article-title":". Case series on the use of aripiprazole for Tourette syndrome.","volume":"8","author":"Murphy","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4088\/PCC.v07n0605","article-title":"Aripiprazole for the treatment of Tourettes disorder.","volume":"7","author":"Padala","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15622970500474770","article-title":"Aripiprazole in patients with Tourette syndrome.","volume":"7","author":"Bubl","year":"2006","journal-title":"World J Biol Psychiatry"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145706006833","article-title":"Aripiprazole is effective in the treatment of Tourettes disorder.","volume":"9","author":"Constant","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hup.798","article-title":". A case series of patients with Tourettes syndrome in the United Kingdom treated with aripiprazole.","volume":"21","author":"Davies","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/08830738060210041701","article-title":"Aripiprazole in childhood and adolescence for Tourette syndrome.","volume":"21","author":"Duane","year":"2006","journal-title":"J Child Neurol"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1345\/aph.1G331","article-title":". Acute dystonia with low-dosage aripiprazole in Tourettes disorder.","volume":"40","author":"Fountoulakis","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/cap.2006.16.505","article-title":"A pilot study of aripiprazole in children and adolescents with Tourettes disorder.","volume":"16","author":"Yoo","year":"2006","journal-title":"Adolesc Psychopharmacol"},{"key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4067\/S0034-98872007000600013","article-title":"Aripiprazole en el tratamiento sintomatico del sindrome de Gilles de la Tourette.","volume":"135","author":"Miranda","year":"2007","journal-title":"Rev Med Chile"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4088\/JCP.v68n0717","article-title":". An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.","volume":"68","author":"Yoo","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/mds.21859","article-title":". Aripiprazole: a treatment for severe coprolalia in refractory Gilles de la Tourette syndrome.","volume":"23","author":"Ben Djebara","year":"2008","journal-title":"Mov Disord"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/cap.2007.061","article-title":". Aripiprazole in children and adolescents with Tourette disorder with or without explosive outbursts.","volume":"18","author":"Budman","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"R26-16-20210128","first-page":"58","article-title":"Aripiprazole for the treatment of Tourettes Syndrome.","volume":"170","author":"Stenstrom","year":"2008","journal-title":"Ugeskr Laeger"},{"key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JCP.0b013e31817d86cc","article-title":". Aripiprazole in a case presenting with Tourette syndrome and obsessive-compulsive disorder.","volume":"28","author":"Winter","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/15622970701762544","article-title":". Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients.","volume":"10","author":"Kawohl","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"R29-16-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/cap.2009.0035","article-title":". Aripiprazole in children and adolescents with Tourettes disorder: an open-label safety and tolerability study.","volume":"19","author":"Lyon","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R30-16-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/cap.2008.0149","article-title":". Open label aripiprazole in the treatment of youth with tic disorders.","volume":"19","author":"Murphy","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R31-16-20210128","first-page":"291","article-title":". Aripiprazolea medical treatment alternative for Tourette syndrome in childhood and adolescence.","volume":"38","author":"Frolich","year":"2010","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"key":"R32-16-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/cap.2009.0125","article-title":". Effectiveness and tolerability of aripiprazole in children and adolescents with Tourettes disorder: a pilot study in china.","volume":"20","author":"Cui","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R33-16-20210128","first-page":"421","article-title":". A control study of aripiprazole and tiapride treatment for tic disorders in children.","volume":"12","author":"Liu","year":"2010","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R34-16-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0897190009358771","article-title":". Aripiprazole for the treatment of adolescent Tourettes syndrome: a case report.","volume":"23","author":"Lewis","year":"2010","journal-title":"Journal of Pharmacy Practice"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201208000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:17:48Z","timestamp":1618035468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201208000-00016"}},"subtitle":["A Case Series of 100 Patients"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31825ac2cb","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}